Omeprazole Dosing for a 15-Year-Old
For a 15-year-old adolescent, the recommended omeprazole dose is 20 mg once daily, taken before meals, for treatment of GERD or erosive esophagitis. This assumes the patient weighs ≥20 kg, which is typical for this age group 1, 2.
Weight-Based Dosing Algorithm
The dosing is determined by weight, not just age:
- If weight ≥20 kg (typical for 15-year-olds): 20 mg once daily
- If weight <20 kg (rare at age 15): 10 mg once daily
This is the FDA-approved dosing for pediatric patients aged 2-16 years 1.
Indication-Specific Considerations
For Symptomatic GERD:
- 20 mg once daily for up to 4 weeks 1
- Administer 30 minutes before the first meal of the day for optimal efficacy
For Erosive Esophagitis:
- 20 mg once daily for 4-8 weeks 1
- If no response after 8 weeks, may extend an additional 4 weeks
- For maintenance of healing: continue 20 mg once daily (studies support up to 12 months) 2, 1
Dosing Range from Clinical Evidence
While the standard dose is 20 mg daily, pediatric guidelines indicate an effective dosage range of 0.7-3.3 mg/kg/day for children aged 2-16 years 2. For a typical 15-year-old weighing 50-60 kg, this translates to approximately 35-200 mg daily, though the standard 20 mg dose is effective for most patients. Studies show that 44% of children heal with 0.7 mg/kg/day and another 28% with 1.4 mg/kg/day 3.
Administration Instructions
Critical timing for efficacy:
- Take before meals (ideally 30 minutes before first meal) 1
- Swallow capsules whole; do not chew
- If unable to swallow: open capsule and sprinkle contents on 1 tablespoon of applesauce, swallow immediately without chewing pellets 1
Important Caveats
Common prescribing errors to avoid:
- Suboptimal timing (not taking before meals) significantly reduces efficacy 4
- Do not exceed 8 weeks without reassessment unless for maintenance therapy
- Antacids may be used concomitantly if needed 1
Drug interactions requiring attention:
- Avoid with rilpivirine, atazanavir, nelfinavir (reduces antiretroviral levels by 40-96%) 1
- Reduces clopidogrel effectiveness by 42-46% 1
- Increases clarithromycin levels if used in combination therapy 1
Pharmacokinetic Considerations
The pharmacokinetics in adolescents aged 6-16 years are comparable to adults, with no dose adjustment needed based on age alone 1, 5. The half-life is approximately 1 hour, similar to adults, and CYP2C19 genotype does not significantly affect dosing in this age group when using standard doses 5.